On September 10, experts across disciplines, from infectious disease clinicians to regulators to representatives from the pharmaceutical industry, convened at the inaugural ImmunOptimize workshop in ...

Research from the Berger lab at Fred Hutch identifies the deubiquitinase USP9X as an important factor helping to increase ...

Patients, pathologists, clinicians, researchers, radiologists and others from around the world recently gathered for the 2024 ...

New work from Fred Hutch Cancer Center virologists shows that gene drive, which pushes a trait through a population, occurs ...

Researchers at Fred Hutchinson Cancer Center, led by Dr. Julie McElrath, Director of the Vaccine and Infectious Disease Division, have found a new way to train our immune system to make antibodies ...

AWS, Deloitte, Microsoft and NVIDIA bring the latest in AI technology, coordination, and compute to the alliance and back with initial funding SEATTLE – Oct. 2, 2024 – Four National Cancer ...

Most often we think about cancer as developing from cells that acquire cancer-driving mutations, but there’s a subset of cancers driven by another culprit: viruses. To date, “seven human viruses have ...

People from sexual and gender minoritized (SGM) communities—including those who identify as lesbian, gay, bisexual, transgender, queer, intersex, asexual, or anyone who doesn’t fit into the ...

On some level, biology is all about regulation, regulation, regulation. One way that our cells regulate their genes is through a process called alternative splicing, which entails the selective ...

After contracting COVID-19, regardless of severity, some individuals experience symptoms that persist for months. This prolonged illness is often referred to as long COVID or post-COVID-19 syndrome ...

During the COVID-19 pandemic, it quickly became clear that certain populations were particularly at risk for severe disease. Individuals undergoing hematopoietic cell transplants (HCT) or chimeric ...